About Chiba Cancer Center
千葉県がんセンターは、千葉県千葉市中央区にある千葉県が運営する医療機関兼研究所。がん診療連携拠点病院に指定されており、がん対策の千葉県における中枢的役割を果たしている。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Chiba Cancer Center
During the past decade, Chiba Cancer Center conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 18 clinical trials were completed, i.e. on
average, 51.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 9 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chiba Cancer Center" #1 sponsor was "Pfizer" with 11 trials, followed by "Hoffmann-La Roche" with 6 trials
sponsored, "Incyte Corporation" with 5 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Kyowa Kirin Co., Ltd."
with 3 trials sponsored. Other sponsors include 19 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chiba Cancer Center"
#1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 2 trials as a collaborator and "Japan Clinical Oncology Group" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were
collaborators in the rest 22 trials.
Clinical Trials Conditions at Chiba Cancer Center
According to Clinical.Site data, the most researched conditions in "Chiba Cancer Center" are
"Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Breast Neoplasms" (3 trials), "Fallopian Tube Cancer" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Chiba Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Chiba Cancer Center
Most popular intervention types in "Chiba Cancer Center" are "Drug" (49 trials), "Other" (6 trials), "Biological" (2 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Paclitaxel" (4 trials), "Palbociclib" (4 trials), "Cyclophosphamide" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Chiba Cancer Center
The vast majority of trials in "Chiba Cancer Center" are
40 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Chiba Cancer Center
Currently, there are NaN active trials in "Chiba Cancer Center".
undefined are not yet recruiting,
11 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 25 completed trials in Chiba Cancer Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Chiba Cancer Center, 3 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 32 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Chiba Cancer Center
Chiba Cancer Center has several departments that took part in Clinical trials: "Chiba cancer center" - 25 trials, "Chiba Children's Hospital" - 6 trials